Suzuka University of Medical Science · Faculty of Medical Engineering

Research keywordsthrombomodulin mutation・protein C activation・factor Xa inhibitor・colorectal cancer models・coagulation biology

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Edoxaban, a factor Xa-specific direct oral anticoagulant, significantly suppresses tumor growth in colorectal cancer colon26-inoculated BALB/c mice2023 · TH Open
• A case of thrombomodulin mutation causing defective thrombin binding with absence of protein C and TAFI activation.2020 · Blood advances

• official_suzuka_result_9584

• Official profile